Compound 5

General Information


DRACP ID  DRACP00548

Peptide Name   Compound 5

Sequence  RTXCXfLRXC

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
PC-12 Lung papillary adenocarcinoma Carcinoma IC50=629µg/ml WST-1 assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Madin-Darby canine kidney cells: IC50=548µg/ml; Human dermal fibroblasts: IC50=534µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys4<---Cys10

N-terminal Modification  C9

C-terminal Modification  Amidation

Other Modification  X=diaminobutyrate; f=D-Phe

Chiral  Mix



Physicochemical Information


Formula  C28H46N12O4S2

Absent amino acids  ADEFGHIKMNPQSVWY

Common amino acids  X

Mass  116958

Pl  8.83

Basic residues  2

Acidic residues  0

Hydrophobic residues  1

Net charge  2

Boman Index  -2493

Hydrophobicity  -9

Aliphatic Index  39

Half Life 
  /

Extinction Coefficient cystines  125

Absorbance 280nm  13.89

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26024044

Title  A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity

Doi 10.1038/srep10558

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.